Gelonghui March 19 丨 Some investors asked Qizheng Tibetan Medicine (002287.SZ) on the investor interactive platform, “In which countries are listed companies' complete vehicles and accessories sold?” The company replied that the company's “Baitai Biotech New Drug Clinical Research Ethane Selenium Project” has been terminated. Anti-cancer drug development has the characteristics of high capital requirements, long cycle time, and relatively high risk. Please pay attention to investment risks.
奇正藏药(002287.SZ)：“百泰生物恶性肿瘤新药临床研究乙烷硒林项目”已终止
Qizheng Tibetan Medicine (002287.SZ): “Baitai Biologics New Drug Clinical Research Ethane Selenium Project” has been terminated
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.